We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Creation of the BioBank, Early Detection and Discovery Biomarkers

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00901680
First Posted: May 14, 2009
Last Update Posted: January 6, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
George Wilson, William Beaumont Hospitals
  Purpose
To establish a multidisciplinary research structure for tissue repository that facilitates projects that bridge specialties that normally may or may not interact.

Condition
Pancreatic Cancer Head and Neck Cancer Breast Cancer

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Creation of the BioBank,To Establish a Multidisciplinary Research Structure That Facilitates Projects That Bridge Specialties That Normally May or May Not Interact.

Resource links provided by NLM:


Further study details as provided by George Wilson, William Beaumont Hospitals:

Biospecimen Retention:   Samples With DNA
Biospecimens to be retained are tissue, blood, whole blood, DNA, RNA, urine saliva,cerebral spinal fluid, amniotic fluid.

Enrollment: 3028
Study Start Date: August 2008
Study Completion Date: January 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Detailed Description:
To establish a multidisciplinary research structure that facilitates projects that bridge specialties that normally may or may not interact. The tissue bank will build the platform for a novel application of translational research that links cutting edge molecular laboratory techniques to clinical outcome studies in a fast and direct manner. Tissue banks can be used for numerous discovery applications such as the identification and structural characterization of human genes, expression analysis, or discovery proteomics. Biological specimens, when coupled with standardized treatment and outcome data, will be essential resources for the identification, characterization, and validation of biomarkers that are predictive of disease and treatment.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Population male/female from inpatient and outpatient hospital settings or doctor offices..
Criteria

Inclusion Criteria:

  • Male and female volunteers

Exclusion Criteria:

  • N/A volunteers
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00901680


Locations
United States, Michigan
William Beaumont Hospitals
Royal Oak, Michigan, United States, 48370
Sponsors and Collaborators
William Beaumont Hospitals
Investigators
Principal Investigator: George Wilson, PhD William Beaumont Hospitals
  More Information

Additional Information:
Responsible Party: George Wilson, George Wilson PhD, William Beaumont Hospitals
ClinicalTrials.gov Identifier: NCT00901680     History of Changes
Other Study ID Numbers: HIC 2008-180
First Submitted: May 13, 2009
First Posted: May 14, 2009
Last Update Posted: January 6, 2017
Last Verified: January 2017

Keywords provided by George Wilson, William Beaumont Hospitals:
Tissue Bank

Additional relevant MeSH terms:
Pancreatic Neoplasms
Head and Neck Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Endocrine Gland Neoplasms
Digestive System Diseases
Pancreatic Diseases
Endocrine System Diseases